Abstract:Increasing evidence suggests that antibiotic administration causes gut injury, negatively affecting nutrient digestion, immune regulation, and colonization resistance against pathogens due to the disruption of gut microbiota. However, the time-course effects of therapeutic antibiotics on alterations of gut microbes and short-chain fatty acids (SCFAs) in young swine are still unknown. In this study, twenty piglets were assigned into two groups and fed commercial diets with or without lincomycin in the first week for a 28-day trial period. Results showed that 1-week lincomycin exposure (LE) did reduce the body weight on day 14 (p = 0.0450) and 28 (p = 0.0362). The alpha-diversity notably reduced after 1-week LE, and then gradually raised and reached the control group level in the second week on cessation of LE, indicated by the variation of Sobs, Chao, Shannon, and ACE index (p < 0.05). Beta-diversity analysis revealed that the distinct microbial cluster existed persistently for the whole trial period between two groups (p < 0.001). The relative abundance of most microbes including fiber-degrading (e.g., Agathobacter and Coprococcus), beneficial (e.g., Lactobacillus and Mitsuokella), or pathogenic bacteria (e.g., Terrisporobacter and Lachnoclostridium) decreased (LDA score > 3), and the concentration of SCFAs also diminished in the feces of 1-week lincomycin-administrated young swine, indicating that therapeutic LE killed most bacteria and reduced SCFA production with gut dysbiosis occurring. After the LE stopped, the state of gut dysbiosis gradually attenuated and formed new gut-microbe homeostasis distinct from microbial homeostasis of young pigs unexposed to lincomycin. The increased presence of potential pathogens, such as Terrisporobacter, Negativibacillus, and Escherichia-Shigella, and decreased beneficial bacteria, such as Lactobacillus and Agathobacter, were observed in new homeostasis reshaped by short-lincomycin administration (LDA score > 3 or p < 0.05), adversely affecting gut development and health of young pigs. Collectively, these results suggested that severe disruption of the commensal microbiota occurred after short-term LE or termination of LE in young swine.Key points• Therapeutic lincomycin exposure induced gut dysbiosis, killing most bacteria and reducing short-chain fatty acid production.• Gut dysbiosis gradually attenuated and formed new homeostasis after lincomycin exposure stopped.• The new homeostasis, increased Escherichia-Shigella etc. and decreased Lactobacillus etc., was potentially harmful to gut health.

Dynamic metabonomic and microbiological response of rats to lincomycin exposure: an integrated microbiology and metabonomics analysis

Impact of lincosamides antibiotics on the composition of the rat gut microbiota and the metabolite profile of plasma and feces

Impacts of changes in intestinal flora on the metabolism of Sprague-Dawley rats

Time-course alterations of gut microbiota and short-chain fatty acids after short-term lincomycin exposure in young swine

The footprints of gut microbial-mammalian co-metabolism.

Gut Microbiota Composition in Relation to the Metabolism of Oral Administrated Resveratrol

Comprehensive Insights into Microcystin-Lr Effects on Hepatic Lipid Metabolism Using Cross-Omics Technologies.

Metabonomic Strategy for the Detection of Metabolic Effects of Probiotics Combined with Prebiotic Supplementation in Weaned Rats

Effects of Broad-Spectrum Antibiotics on the Metabolism and Pharmacokinetics of Ginsenoside Rb1: a Study on Rats׳ Gut Microflora Influenced by Lincomycin.

Effects of microcystin-LR on bacterial and fungal functional genes profile in rat gut.

A Strategy for the Targeted Metabolomics Analysis of 11 Gut Microbiota-Host Co-Metabolites in Rat Serum, Urine and Feces by Ultra High Performance Liquid Chromatography–tandem Mass Spectrometry

Integrated Analysis of the Alterations in Gut Microbiota and Metabolites of Mice Induced After Long-Term Intervention With Different Antibiotics

Systems Responses of Rats to Aflatoxin B1 Exposure Revealed with Metabonomic Changes in Multiple Biological Matrices

Metabolic response to oral microcystin-LR exposure in the rat by NMR-based metabonomic study.

Dosage Effects of Lincomycin Mycelial Residues on Lincomycin Resistance Genes and Soil Microbial Communities.

Integration of metagenomic and metabolomic insights into the effects of microcystin-LR on intestinal microbiota of Litopenaeus vannamei

Liquid Chromatography/Mass Spectrometry Reveals the Effect of Lactobacillus Treatment on the Faecal Metabolite Profile of Rats with Chronic Renal Failure.

1H NMR Metabolomics on Pigs’ Liver Exposed to Antibiotics Administration: An Explorative Study

Integrated Metabolomics and 16S Rrna Sequencing to Investigate the Regulation of Chinese Yam on Antibiotic-Induced Intestinal Dysbiosis in Rats

Toxicologic, Transcriptomic, and Metabolomic Insights into the Effect of a Mixture of 26 Veterinary Antimicrobials on Rat Liver.

Antibiotics-Induced Depletion of Rat Microbiota Induces Changes in the Expression of Host Drug-Processing Genes and Pharmacokinetic Behaviors of CYPs Probe Drugs